Skip to main content
Explore URMC
menu

A Study of INCMGA00012 in Metastatic Merkel Cell Carcinoma

Research Question:
What is the clinical activity and safety of INCMGA00012 in participants with metastatic merkel cell carcinoma (MCC)?

Basic Study Information

Purpose:
The purpose of this study is to assess the clinical activity and safety of INCMGA00012, a monoclonal antibody, in participants with metastatic merkel cell carcinoma (MCC).

Location: University of Rochester Medical Center
Study Reference #: IMEL19023

Lead Researcher (Principal Investigator)

Lead Researcher:  Adrienne Victor

Study Contact Information

Study Coordinator: Park Bogan
Phone: (585) 276-4415
Email: Park_Bogan@URMC.Rochester.edu

Additional Study Details

Return to Search